Neil INHABER,Noel JOHNSON,Dirk FENGELS,Ian CROSBIE
申请号：
US15985617
公开号：
US20180344917A1
申请日:
2018.05.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.
